Trials / Sponsors / Se-Hoon Lee
Se-Hoon Lee
Academic / Other · 7 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC Non Small Cell Lung Cancer | Phase 2 | 2026-04-30 |
| Recruiting | Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Small Cell Carcinoma of Lung | Phase 2 | 2025-05-13 |
| Active Not Recruiting | Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients NSCLC | Phase 2 | 2023-01-02 |
| Completed | Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects Lung Cancer | Phase 2 | 2021-06-11 |
| Terminated | AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer SCLC, Recurrent | Phase 2 | 2020-09-18 |
| Completed | Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects Small Cell Lung Cancer | Phase 2 | 2020-06-17 |
| Recruiting | Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy Lung Cancer | — | 2018-04-11 |